Právní předpis byl sestaven k datu 12.05.2009.
Zobrazené znění právního předpisu je účinné od 13.05.2009 do 12.05.2009.
114
VYHLÁŠKA
xx xxx 17. xxxxx 2009,
xxxxxx xx xxxx vyhláška x. 384/2007 Xx., x xxxxxxx xxxxxxxxxxxx xxxxxx
Xxxxxxxxxxxx xxxxxxxxxxxxx stanoví podle §39c xxxx. 1 xxxxxx č. 48/1997 Xx., x veřejném xxxxxxxxxx pojištění x x xxxxx x xxxxxxxx xxxxxxxxx souvisejících xxxxxx, ve xxxxx xxxxxx č. 261/2007 Xx.:
Xx. X
Xxxxxxx k xxxxxxxx č. 384/2007 Sb., x xxxxxxx xxxxxxxxxxxx xxxxxx, zní:
"Xxxxxxx k xxxxxxxx x. 384/2007 Xx.
Xxxxxx referenčních skupin
xxxxx xxxx- xxxxxxxx xxxxxxx | xxxxxxxxxxxx skupina | xxxxx xxxxxxxxxx skupiny | xxxxxxxxxx xxxxxxx*) | xxxxxx xxxxx v referenční xxxxxxx převažující |
1 | Xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x xxxxxxxx choroby xxxxx | 1/2 | xxxxxx x terapii gastroduodenální xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxxx X2 xxxxxxxxx, xxxxxx. | A02BA01 xxxxxxxxx, X02XX02 xxxxxxxxx, X02XX03 xxxxxxxxx |
1/3 | xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x refluxní xxxxxxx xxxxx, inhibitory xxxxxxxxx xxxxx, p.o. | X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxxxx, A02BC03 lansoprazol, X02XX05 xxxxxxxxxxx | ||
1/4 | xxxxxx x terapii xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxxx xxxxx, xxxxxx. | X02XX01 omeprazol, X02XX02 xxxxxxxxxxx, A02BC05 xxxxxxxxxxx | ||
2 | Xxxxxxxxxxxx | 2/1 | xxxxxxxxxxxx, x.x. | X03XX04 mebeverin, X03XX06 xxxxxxxxx xxxxxx, A03AD02 xxxxxxxxxx, X03XX01 butylskopolamin |
2/2 | xxxxxxxxxxxx, xxxxxx. | A03AD01 xxxxxxxxx, X03XX02 xxxxxxxxxx | ||
3 | Xxxxxxxxxxx | 3/1 | xxxxxxxxxxx, x.x. | X03XX01 xxxxxxxxxxxxx, A03FA03 xxxxxxxxxx, X03XX xxxxxxx |
4 | Xxxxxxxxxxx | 4/1 | xxxxxxxxxxx, xxxxxxx, x.x. | X04XX01 xxxxxxxxxxx, X04XX02 xxxxxxxxxxx |
4/2 | xxxxxxxxxxx, xxxxxxx, parent. x xxxx. xxxxxxxx | X04XX01 xxxxxxxxxxx, X04XX02 xxxxxxxxxxx, X04XX05 xxxxxxxxxxxx | ||
4/3 | xxxxxxxxxxx, xxxxxxx, x.x | X06XX03 thiethylperazin, A04AD xxxxxxxx | ||
5 | Xxxxxx x terapii xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx | 5/1 | xxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxx onemocnění, xxxxxxxx xxxxxxxxxxxxxxxx x xx xxxxx xxxxxxx, x.x. | A07EC01 sulfasalazin, X07XX02 xxxxxxxxx |
6 | Xxxxxxxxxxxxx xxxxxxxxxxxxxx | 6/1 | xxxxxxxxxxxxx xxxxxxxxxxxxxx, x.x. | X07XX xxxxxxxxxxxxx xxxxxxxxxxxxxx - Xxxxxxxxxxx xxxx, X07XX01 organismy xxxxxxxxxxx xxxxxxxx xxxxxxx, X07XX02 Xxxxxxxxxxxxx xxxxxxxx sicatus |
7 | Xxxxxxxxxxxxx xxxxxxxxx | 7/1 | xxxxxxxxxxxxx přípravky, xxxxxxxxxxxxx xxxxxx xxxxx, x.x. | X09XX02 multienzymové xxxxxxxxx - mikronizované xxxxxx xxxxx xxx 20&xxxx;000 U x xxxxx xxxxxxx |
8 | Xxxxxx x terapii xxxxxxx - xxxxxxxx | 8/1 | xxxxxx x xxxxxxx diabetu, insulin xxxxxx - xxxxxxxx, xxxxx. | X10XX01 xxxxxxx xxxxxx rychle xxxxxxxx, X10XX01 xxxxxxx xxxxxx xxxxxxx xxxxxx působící |
8/2 | xxxxxx k xxxxxxx xxxxxxx, xxxxxxx xxxxxx - cartridge, xxxxxxx xxxxxxxx - xxxxxxxx x xxxxxxxxx, parent. | X10XX01 xxxxxxx lidský, X10XX04 xxxxxxx lispro, X10XX05 xxxxxxx xxxxxx, X10XX06 insulin glulisin, X10XX01 xxxxxxx xxxxxx, X10XX01 insulin xxxxxx, X10XX04 xxxxxxx lispro, X10XX05 xxxxxxx xxxxxx, | ||
8/3 | xxxxxx x xxxxxxx xxxxxxx, xxxxxxxx a xxxxxxx xxxxxx xxxxxxxx, xxxxxx. | X10XX04 insulin xxxxxxx, X10XX05 xxxxxxx xxxxxxx | ||
9 | Léčiva x terapii xxxxxxx | 9/1 | xxxxxx x xxxxxxx xxxxxxx, xxxxxxxx xxxxxxxxxxxx - X. x II. generace, x.x. (xxxxx xxxxxxxxx, xxxxxxxxxx a xxxxxxxxxxx) | X10XX01 xxxxxxxxxxxx, X10XX03 xxxxxxxxxx, |
9/2 | xxxxxx x xxxxxxx xxxxxxx, deriváty xxxxxxxxxxxx - X. xxxxxxxx, x.x. | X10XX07 xxxxxxxx, A10BB09 xxxxxxxxx, X10XX12 glimepirid | ||
9/3 | xxxxxx x terapii xxxxxxx, xxxxxxxxx, x.x. | A10BG02 xxxxxxxxxxxx, A10BG03 xxxxxxxxxxx | ||
9/4 | xxxxxx k xxxxxxx xxxxxxx, xxxxxxx, x.x. | X10XX02 repaglinid, X10XX03 xxxxxxxxxx | ||
9/5 | léčiva k xxxxxxx diabetu, léčiva xxxxxxxxxxx inkretinový xxxxxx | X10XX01 sitagliptin, X10XX02 xxxxxxxxxxxx, X10XX04 exenatid, X10XX07 xxxxxxxxxx | ||
10 | Xxxxxx x xxxxxxx xxxxxxxx xxxxxxxx | 10/1 | xxxxxx x terapii xxxxxxxx xxxxxxxx, xxxx xxxxxxx, x.x. | X12XX04 xxxxxxxxx xxxxxxxx, X12XX07 xxxxxxx xxxxxxxx |
10/2 | léčiva x xxxxxxx xxxxxxxx xxxxxxxx, xxxx xxxxxxx, x.x. | X12XX06 xxxxxxx xxxxxxxxx, A12CC09 orotát xxxxxxxxx | ||
11 | Xxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxx metabolismu | 11/1 | xxxxxx x xxxxxxxxxx xxxxxxxxxxx terapii xxxxxxxxx xxxxxx lipidového metabolismu, xxxxxx. | A16AB03 xxxxxxxxxx xxxx, A16AB04 xxxxxxxxxx xxxx |
12 | Xxxxxx x xxxxxxx xxxx x profylaxi tromboembolických xxxxxxxxxx | 12/1 | xxxxxx x terapii nebo x xxxxxxxxx tromboembolických xxxxxxxxxx, xxxxxxxxxxxxxxxx hepariny, xxxxx xxxx určené xxxxxxxxx x profylaxi XXX, xxxxxx. | X01XX04 xxxxxxxxxx, X01XX05 enoxaparin, X01XX06 nadroparin, X01XX08 xxxxxxxxx, X01XX12 xxxxxxxxx |
12/2 | xxxxxx x terapii xxxx x profylaxi xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxxxxxx xxxxxxxx, xxxxx xxxx xxxxxx xxxxxxxxx x xxxxxxx TEN, xxxxxx. | X01XX04 dalteparin, B01AB05 xxxxxxxxxx, B01AB06 nadroparin, X01XX08 xxxxxxxxx, X01XX12 xxxxxxxxx | ||
12/3 | léčiva k xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxx inhibitory xxxxxxx Xx x xxxxxxxx, xxxxxx. | X01XX01 xxxxxxxxx, X01XX02 xxxxxxxxx, B01AE06 xxxxxxxxxxx | ||
13 | Léčiva x xxxxxxx xxxx x profylaxi xxxxxxxxxxxxxxxxx xxxxxxxxxx | 13/1 | xxxxxx x terapii nebo x profylaxi xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxx xxxxx XXX xx receptor, x.x. | X01XX04 klopidogrel, X01XX05 xxxxxxxxxx, |
13/2 | xxxxxx x terapii nebo x profylaxi xxxxxxxxxxxxxxxxx xxxxxxxxxx, přímé xxxxxxxxxx xxxxxxx Xx x xxxxxxxx, p.o. | X01XX07 xxxxxxxxxx, B01A xxxxxxxxxxx, X01X xxxxxxxx | ||
14 | Xxxxxxxxxx xxxxxx x xxxxxxx plicní arteriální xxxxxxxxxx (XXX) | 14/1 | xxxxxxxxxx léčiva k xxxxxxx plicní xxxxxxxxxx xxxxxxxxxx (XXX), xxxxxx. x xxxxx. xxxxxxxx | X01XX09 xxxxxxxxxxxx, X01XX11 xxxxxxxx, X01XX21 xxxxxxxxxxxx |
14/2 | xxxxxxxxxx xxxxxx k xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx (XXX), p.o. | X02XX01 xxxxxxxx, C02KX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxx, X02X tezosentan | ||
15 | Xxxxxxxxxxxxx, xxxxxx. | 15/1 | xxxxxxxxxxxxx, enzymy, xxxxxx. | X01XX02 xxxxxxxxx, X01XX04 xxxxxxxxx, X01XX11 xxxxxxxxxxxx |
16 | Xxxxxxxxxxxxxxxxx - xxxxxxxxxxxxx | 16/1 | xxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, p.o. | X02XX02 xxxxxxxx xxxxxxxxxxx, X02XX03 xxxxxxxx xxxxxxxxxxxxxxxxxxx |
16/2 | antifibrinolytika, xxxxxxxxxxxxx, xxxxxx. | B02AA02 xxxxxxxx xxxxxxxxxxx, X02XX03 xxxxxxxx xxxxxxxxxxxxxxxxxxx | ||
17 | Xxxxxx x xxxxxxx xxxxxx - soli xxxxxx | 17/1 | xxxxxx x xxxxxxx xxxxxx, xxxxxxxxx xxxx xxxxxxxxx xxxxxx, p.o. | X03XX02 xxxxxxx xxxxxxxxx, X03XX07 xxxxx xxxxxxxxx, B03AB02 xxxxxxx xxxxxx x xxxxxxxxxxx |
17/2 | xxxxxx k xxxxxxx anémií, trojmocné xxxxxx, xxxxxx. | B03AC02 xxxxxxx železa x xxxxxxxxxxx, X03XX07 xxxxxxxx xxxxx-xxxxxxxx | ||
18 | Xxxxxxx xxxxxxxxxxx xxxxxxxxxxx působením xx xxxxxxxx xxxxxxxxxxxxxx | 18/1 | faktory xxxxxxxxxxx xxxxxxxxxxx, xxxxxx. | B03XA01 xxxxxxxxxxxxx (epoetin xxxx), X03XX02 xxxxxxxxxxx alfa, X03XX03 xxxxxxxxxx (Xxxxxx-xxxxxxxxxxxxxxxx- xxxxxxx xxxx), xxxxxxx xxxx, xxxxxxx xxxxx, xxxxxxx xxxx |
20 | Xxxxxxxx XX k xxxxxxx xxxxxx xxxxxxxx | 20/1 | xxxxxxxx XX x terapii xxxxxx xxxxxxxx - xxxxxxx xxxxxxxx xxxxxxxx, subling. | X01XX02 xxxxxxxx xxxxxxxxx, X01XX08 xxxxxxxxx xxxxxxxx |
20/2 | xxxxxxxx NO x xxxxxxx xxxxxx xxxxxxxx - xxxxxxx dlouhodobá, x.x. | X01XX02 xxxxxxxx xxxxxxxxx, C01DA08 xxxxxxxxx xxxxxxxx, X01XX14 xxxxxxxxx xxxxxxxxxx, X01XX12 xxxxxxxxxx | ||
20/3 | xxxxxxxx NO k xxxxxxx xxxxxx xxxxxxxx, xxxxxx. | C01DA02 glycerol xxxxxxxxx, C01DA08 xxxxxxxxx xxxxxxxx | ||
21 | Antihypertenziva | 21/1 | xxxxxxxxxxxxxx xxxxx xxxxxxxx centrálně i xxxxxxxxx, p.o. (kromě xxxxxxxxx) | C02AB01 xxxxxxxxxx, X02XX05 moxonidin, C02AC06 xxxxxxxxxx, X02XX06 urapidil |
22 | Xxxxxxxxx | 22/1 | xxxxxxxxx, x.x. | C03AA03 xxxxxxxxxxxxxxxxxx, C03BA04 xxxxxxxxxxxx, X03XX11 xxxxxxxxx, C03BA xxxxxxxxx |
23 | Xxxxxxxxxxxxxxxx - xxxx-xxxxxxxxx | 23/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxx, x.x. | X07XX17 xxxxxxxxxx, X07XX02 xxxxxxxxxx (xxxxxxxxxxxxx xxxxxx formy), X07XX03 xxxxxxxx, |
23/2 | antihypertenziva, xxxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxx xxxxxxxx, x.x. | X07XX02 xxxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X07XX04 xxxxxxxx, X07XX05 xxxxxxxxx, C07AB07 bisoprolol, X07XX08 xxxxxxxxxx, X07XX12 xxxxxxxxx, X07XX02 xxxxxxxxxx | ||
24 | Antihypertenziva - xxxxxxxxx xxxxxxxxxx xxxxxx | 24/1 | xxxxxxxxxxxxxxxx, blokátory xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx xxxx dlouhodobě xxxxxxxx, x.x. | C08CA01 xxxxxxxxx, X08XX02 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX03 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX08 xxxxxxxxxxx, X08XX09 lacidipin, C08CA10 xxxxxxxxxx, C08CA12 xxxxxxxxxx, X08XX13 xxxxxxxxxxxx |
24/2 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx typu krátkodobě x střednědobé xxxxxxxx, x.x. | C08CA02 xxxxxxxxx (xxxxxxxxxxxxx lékové xxxxx), X08XX03 isradipin (neretardované xxxxxx formy), X08XX05 xxxxxxxxx (xxxxxxx xxxxxx xxxxx) | ||
24/3 | antihypertenziva, xxxxxxxxx xxxxxxxxxx xxxxxx fenylalkylaminového x benzothiazepinového typu, x.x. | X08XX01 xxxxxxxxx, X08XX01 xxxxxxxxx | ||
25 | Xxxxxxxxxxxxxxxx - xxxxxx xxxxxxxx na systém xxxxx- xxxxxxxxxxx-xxxxxxxxxx | 25/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX xxxxxxxxxx a xxxxxxxxxxx xxxxxxxx, p.o | X09XX01 xxxxxxxxx, X09XX02 enalapril, X09XX06 quinapril |
25/2 | antihypertenziva, xxxxxxxxxx XXX xxxxxxxxxx xxxxxxxx, x.x. | X09XX03 xxxxxxxxxx, X09XX04 perindopril, X09XX05 xxxxxxxx, C09AA08 xxxxxxxxxx, X09XX09 xxxxxxxxxx, X09XX10 xxxxxxx xxxxx, X09XX11 xxxxxxxxx, C09AA13 xxxxxxxxx, C09AA16 xxxxxxxxx | ||
25/3 | xxxxxxxxxxxxxxxx, xxxxxxxxxxx xxxxxxxxxxxx XX xxxxxxx, x.x. | X09XX01 losartan, C09CA02 xxxxxxxxxx, X09XX03 xxxxxxxxx, X09XX04 ibersartan, X09XX06 xxxxxxxxxxx, X09XX07 xxxxxxxxxxx, X09XX08 xxxxxxxxxx | ||
25/4 | xxxxxxxxxxxxxxxx, xxxxxxxxxxx aldosteronu, x.x. | X03XX01 xxxxxxxxxxxxx, X03XX04 xxxxxxxxx | ||
26 | Periferní xxxxxxxxxxxxxx | 26/1 | xxxxxxxxx xxxxxxxxxxxxxx, x.x. (xxxxx xxxxxxxxxxxxxxx námelových xxxxxxxxx x xxxxxxxxx dihydroergokristinu) | X04XX02 xxxxxxxx xxxxxxxxx, X04XX03 xxxxxxxxxxxx, X04XX02 xxxxxxxxxx, X04XX21 xxxxxxxxxxxxx, X04XX04 xxxxxxxxx xxxxxxxxx |
26/2 | xxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. | X04XX02 xxxxxxxxx, X04XX03 xxxxxxxxxxxx, X04XX xxxxxxxx | ||
27 | Xxxxxxxxxxx | 27/1 | xxxxxxxxxxx, p.o. | C05BX01 xxxxxxxxx vápenatý, X05XX04 xxxxxxxxxx, X05XX53 diosmin xxxxxxxxx X05XX01 tribenosid, X05XX escin |
28 | Xxxxxxxxxxxxxx | 28/1 | hypolipidemika, xxxxxxx, p.o. | X10XX01 xxxxxxxxxxx, X10XX02 xxxxxxxxxx, X10XX03 xxxxxxxxxxx, X10XX04 xxxxxxxxxxx, X10XX05 xxxxxxxxxxxx, X10XX07 rosuvastatin |
28/2 | hypolipidemika, xxxxxxx, p.o. | X10XX02 xxxxxxxxxx, X10XX05 fenofibrát, X10XX08 ciprofibrát | ||
29 | Xxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx | 29/1 | xxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx x xxxxxxx xxxxxxx, (xxxxx xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxx xxxxxxxxxxx) | X01XX01 xxxxxxxx, D01AA02 xxxxxxxx, X01XX01 klotrimazol, X01XX03 xxxxxxxx, X01XX08 xxxxxxxxxxx, X0x XX10 xxxxxxxxx, X01XX11 oxikonazol, X01XX16 xxxxxxxxxxx, D01AE14 xxxxxxxxxx, X01XX15 terbinafin, X01XX22 naftifin |
29/2 | antimykotika xxxxxxxxx x xxxxxxxxxxxx x lokální terapii, xxxxxxx | X01XX04 xxxxxxxx xxxxxxxxxxxx, X01XX jiná xxxxxxxxxxxx x xxxxxxx xxxxxxx | ||
30 | Antipsoriatika xxxxxxxxx x xxxxxxxxxxxx | 30/1 | xxxxxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxxx x xxxxxxx terapii, dehty | X05XX dehty, X05XX xxxxx (odbarvený dehet) |
30/2 | xxxxxxxxxxxxxx používaná v xxxxxxxxxxxx k xxxxxxx xxxxxxx, xxxx xxxxxx xxx xxxxx | X05XX02 xxxxxxxxxxxx, D05AX03 calcitriol, X05XX04 xxxxxxxxxx, X05XX05 xxxxxxxxx | ||
31 | Xxxxxxxxxxx xxxxxxxxx k lokální xxxxxxx | 31/1 | antibiotika xxxxxxxxx x xxxxxxx xxxxxxx | X06XX01 xxxxxxxx xxxxxxxx, X06XX09 xxxxxxxxx |
32 | Xxxxxxxxxxxxxxx používané x xxxxxxx xxxxxxx - xxxxx x středně xxxxx | 32/1 | xxxxxxxxxxxxxxx xxxxxxxxx x lokální xxxxxxx, xxxxx a xxxxxxx xxxxx 1. x 2. xxxxxxxx | X07XX19 xxxxxxxxxxxx acetát (0,01%), X07XX04 fluocinolon xxxxxxxx (0,01%), D07AA02 xxxxxxxxxxxxx xxxxxx (1,0%), X07XX03 xxxxxxxxxxx (0,4%), X07XX09 triamcinolon xxxxxxxx (0,1%) |
32/2 | kortikosteroidy používané x xxxxxxx xxxxxxx, xxxxx x xxxxxxx xxxxx 3. x 4. xxxxxxxx | D07AB10 xxxxxxxxxxxxx (0,05%), X07XX08 xxxxxxx, X07XX02 liydrokortison xxxxxxx (0,1%) | ||
33 | Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxx x velmi xxxxx | 33/1 | xxxxxxxxxxxxxxx používané x lokální xxxxxxx, xxxxx a velmi xxxxx 1. x 2. xxxxxxxx | D07AC04 xxxxxxxxxxx acetonid (0,05%- 0,2%), D07AC03 xxxxxxxxxxxxxx (0,25%) |
33/2 | xxxxxxxxxxxxxxx xxxxxxxxx x lokální xxxxxxx, xxxxx x xxxxx xxxxx 3. x 4. xxxxxxxx | X07XX01 xxxxxxxxxxxx valerát (0,1%), X07XX01 xxxxxxxxxxxx xxxxxxxxxxx (0,05%), X07XX17 xxxxxxxxxx xxxxxxxxx (0,05%), X07XX12 Xxxxxxxxxxx xxxxxxxxx (0,05%), X07XX02 Xxxxxxxxxx (0,1%), X07XX01 xxxxxxxxxx xxxxxxxxx (0,05%), X07XX14 methylprednisolon xxxxxxxx (0,1%), D07AC13 xxxxxxxxx xxxxxx (0,1%), X07XX18 xxxxxxxxxxxx | ||
34 | Xxxxxxxxxxx a xxxxxxxxxxxxxx | 34/1 | antiseptika a xxxxxxxxxxxxxx - xxxxxxxxxx xxxxxxxxx xxxxx | X08XX xxxxxxxxxx xxxxxxxxxx xxxxxxxxx xxxxx |
35 | Xxxxxx xxxxxxxxx k xxxxxxx xxxxxxx xxxx xxxxxxxx | 35/1 | xxxxxx xxxxxxxxx x xxxxxxx terapii xxxx xxxxxxxx, retinoidy | X10XX01 xxxxxxxxx, X10XX03 xxxxxxxx, X10XX04 xxxxxxxxxxxx |
35/2 | xxxxxx používaná x xxxxxxx terapii xxxx xxxxxxxx, xxxxxxx xxxxxx | X10XX01 xxxxxxx peroxid, X10XX03 xxxxxxxx xxxxxxxx | ||
35/3 | xxxxxx používaná x xxxxxxx xxxxxxx xxxxxxxxxxxx, xxxxxxxxxxxx xxxxx | X10XX01 xxxxxxxxxxx, D10AF02 xxxxxxxxxxxx | ||
36 | Xxxxxxxxxxxxxxx xxxxxxxxx x lokální terapii xxxxxxxx dennatitidy | 36/1 | xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx | X11XX14 xxxxxxxxxx, X11XX15 pimelcrolimus |
37 | Xxxxxxxxxxxxx xxxxxxxxxxxx | 37/1 | xxxxxxxxxxxxx xxxxxxxxxxxx, lok. xxxx xxx. aplikace | X01XX02 xxxxxxxxxxx, X01XX05 xxxxxxxx, X01XX12 fentikonazol |
38 | Xxxxxxxxxxxxx antiseptika | 38/1 | xxxxxxxxxxxxx xxxxxxxxxxx, xxx. nebo xxx. xxxxxxxx, (xxxxx xxxxxxxxx xxxxxxxxxxxx laktobacillus) | G0IAX03 xxxxxxxxxxxxx, G01AX11 xxxxxxxxx xxx, X01XX xxxxxxxxxxxx xxxxx |
39 | Xxxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx terapii | 39/1 | xxxxxxxxxxxxx xxxxxxxxxxx, xxx. xxxx xxx. xxxxxxxx | X01XX02 xxxxxxxxx, X01XXX0 xxxxxxxxxxx, X01XX12 xxxxxxxxxx |
40 | Xxxxxxxxxxxxxx | 40/1 | xxxxxxxxxxxxxx, xxxxxx. | G02AD01 xxxxxxxxx, X02XX04 xxxxxxxxxx |
41 | Inhibitory xxxxxxxxxx | 41/1 | xxxxxxxxxx prolaktinu, xxxxxxxxxxxx xxxxxxxx I. xxxxxxxx, p.o. | G02CB01 xxxxxxxxxxxx, G02CB0G xxxxxxxx |
41/2 | xxxxxxxxxx prolaktinu, dopaninergní xxxxxxxx XX. xxxxxxxx, x.x. | X02XX03 kabergolin, X02XX04 xxxxxxxxxx | ||
42 | Xxxxxxxxx | 42/1 | estrogeny, x.x. | G03CA03 xxxxxxxxx, X03XX04 xxxxxxx, X03XX05 xxxxxxx |
42/2 | xxxxxxxxx, xxxxxxx xxx. xxxxxxxx | X03XX03 xxxxxxxxx, X03XX04 xxxxxxx | ||
43 | Xxxxxxxxxx | 43/1 | xxxxxxxxxx X. generace, x.x. | G03DA02 xxxxxxxxxxxxxxxxxx, X03XX02 xxxxxxxxxxxxx, X03XX03 xxxxxxxxxxx |
43/2 | xxxxxxxxxx XX. xxxxxxxx, x.x. | G03DA04 xxxxxxxxxxx, X03XX01 xxxxxxxxxxxxx | ||
43/3 | xxxxxxxxxx, parent. | X03XX03 xxxxxxxxxxxxxxxxxx, X03XX04 xxxxxxxxxxx (xxxxxxx xxxxxx formy) | ||
44 | Gonadotropiny | 44/1 | xxxxxxxxxxxxx xxxxxxxx, xxxxxx. | X03XX01 choriový xxxxxxxxxxxx, X03XX08 xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxxx |
44/2 | xxxxxxxxxxxxx xxxxxxx, xxxxxx. | X03XX02 xxxxxxxxxxxx xxxxxx, xxxxxxxxxxxx xxxxxx xxxxxx čištěný, G03GA04 xxxxxxxxxxxxx, xxxxxxxxxxxxx xxxxxx xxxxxxx, X03XX05 folitropin xxxx, X03XX06 xxxxxxxxxx xxxx, X03XX07 xxxxxxxx xxxx | ||
45 | Xxxxxx xxxxxxxxxxxx | 45/1 | močová xxxxxxxxxxxx, xxxxxxxxxxxxx xxxxx, x.x. a xxxxxxxxx. xxxxxxxx | G04BD04 xxxxxxxxxx, X04XX06 xxxxxxxxxx, X04XX07 xxxxxxxxxx, X06XX09 trospium xxxxxxx |
45/2 | xxxxxx spasmolytika, xxxxxxxxxxx formy, x.x. | X04XX07 xxxxxxxxxx, G04BD08 xxxxxxxxxxx, X04XX10 xxxxxxxxxxx, X04XX11 fesoterodin | ||
46 | Xxxxxx x terapii xxxxxxx xxxxxxxxxxx xxxxxxxx | 46/1 | xxxxxx k xxxxxxx xxxxxxx hyperplazie xxxxxxxx, antagonisté alfa xxxxxxxxxxxx xxxxxxxxx, x.x. | X02XX04 xxxxxxxxx, X04XX01 xxxxxxxxx, G04CA02 xxxxxxxxxx, X04XX03 xxxxxxxxx |
46/2 | xxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx prostaty, ostatní, x. x. | X04XX01 xxxxxxxxxx, X04XX03 xxxxxxxxxxx | ||
47 | Xxxxxxxxxxx xxxxxxxxx xxxxxxx | 47/1 | antagonisté xxxxxxxxx hormonu, xxxxxxxxxx xxxxxxxx, xxxxxx. | X01XX01 xxxxxxxxxxxx, X01XX02 xxxxxxxxx |
47/2 | xxxxxxxxxxx ristového hormonu - dlouhodobě působící, xxxxxx. | X01XX02 xxxxxxxxx, X01XX03 xxxxxxxxx | ||
48 | Xxxxxxxxxxx gonadotropin uvolňujícího xxxxxxx | 48/1 | antagonisté xxxxxxxxxxxx - xxxxxxxxxxxx xxxxxxx, xxxxxx. | H01CC01 xxxxxxxxx, X010002 cetrorelix |
49 | Xxxxxxxxxxxxxxx k xxxxxxxxx terapii | 49/1 | xxxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxxxxxxx účinkem, p.o. | X02XX04 xxxxxxxxxxxxxxxxx, X02XX07 xxxxxxxxx, H02AB08 triatncinolon |
49/2 | xxxxxxxxxxxxxxx s xxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx, xxxxxx. - xxxxxxx | X02XX01 xxxxxxxxxxxx (depotní xxxxxx xxxxx), X02XX04 xxxxxxxxxxxxxxxxx (xxxxxxx xxxxxx formy) | ||
50 | Xxxxxxxxxxxxxxx léčiva | 50/1 | xxxxxxxxxxxxxxx xxxxxx, x.x. | X03XX02 xxxxxxxxxxxxxxxx, X03XX01 xxxxxxxxxx, X03XX02 xxxxxxxxxx |
51 | Xxxxxxxxxxxx | 51 /1 | tetracykliny, x.x. | X01XX02 xxxxxxxxxx, X01XX08 xxxxxxxxxx |
52 | Xxxxxxxxxx s úzkým xxxxxxxx xxxxxx | 52/1 | xxxxxxxxxx s xxxxx xxxxxxxx, x.x. | J01CE02 xxxxxxxxxxxxxxxxxxxxx, X01XX06 xxxxxxxxxxx, X01XX10 xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx |
53 | Xxxxxxxxxxxxx | 53/1 | xxxxxxxxxxxxx X. xxxxxxxx, x.x. | X01XX01 xxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX04 xxxxxxxx, |
53/2 | xxxxxxxxxxxxx XX. xxxxxxxx, p.o. | J01DC02 xxxxxxxxx xxxxxx, X01XX10 xxxxxxxxx | ||
53/3 | xxxxxxxxxxxxx I. xxxxxxxx, xxxxxx. | X01XX03 xxxxxxxxx, X01XX04 xxxxxxxxx | ||
53/4 | xxxxxxxxxxxxx XXX. xxxxxxxx, xxxxxx. (kromě xxxxxxxxxxxx) | X01XX01 cefotaxim, J01DD02 xxxxxxxxxx, X01XX04 ceflriaxon | ||
54 | Xxxxxxxxxxx | 54/1 | xxxxxxxxxxx, xxxxxx. | X01XX02 xxxxxxxxx, J01DH03 ertapenem |
55 | Makrolidová, xxxxxxxxx, xxxxxxxxxx x linkosamidová xxxxxxxxxxx | 55/1 | xxxxxxxxx, x.x. | X01XX01 erythromycin, X01XX02 spiramycin, X01XX06 xxxxxxxxxxxxx, X01XX09 xxxxxxxxxxxxxx, X01XX10 xxxxxxxxxxxx |
55/2 | linkosamidy, x.x. | J01FF01 klindamycin, X01XX02 xxxxxxxxxx | ||
56 | Xxxxxxxxx | 56/1 | xxxxxxxxx, x.x. (kromě xxxxxxxxxxxxx) | X01XX01 xxxxxxxxx, J01MA02 xxxxxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX06 xxxxxxxxxxx, X01XX12 xxxxxxxxxxxx |
57 | Imidazolové xxxxxxxx | 57/1 | xxxxxxxxxxx xxxxxxxx, p.o. | J01XD01 xxxxxxxxxxxx, J01XD03 omidazol |
58 | Xxxxxxxxxxxx x xxxxxxxxx terapii | 58/1 | xxxxxxxxxxxx x xxxxxxxxx xxxxxxx, xxxxxxxxxx xxxxxxxx, x.x. | J02AC03 xxxxxxxxxxx, X02XX04 xxxxxxxxxxx |
59 | Xxxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxx xxxxxxxxx herpesvirus xxxxxxx | 59/1 | xxxxxxxxx xxxxxxxxxxxx x xxxxxxx xxxxxxx vyvolaných herpes xxxxx xxxxxxx, x.x. | X05XX01 aciklovir, X05XX09 xxxxxxxxxxx, X05XX11 xxxxxxxxxxxx, X05XX15 brivudin |
60 | Xxxxxxxxxxxxxxxxx | 60/1 | xxxxxxxxxxxxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxx reverzní xxxxxxxxxxxx, xxxxx xxx XXX xxxxxxx, p.o. | X05XX02 xxxxxxxxx, J05AF04 xxxxxxxx, X05XX06 xxxxxxxx, J05AF09 xxxxxxxxxxxx |
60/2 | xxxxxxxxxxxxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx, xxxxx xxx HBV infekce, x.x. | X05XX08 xxxxxxxx, X05XX10 xxxxxxxxx | ||
61 | Xxxxxxxxxx xxxxxxxxxxxxxx | 61/1 | xxxxxxxxxx xxxxxxxxxxxxx, x. x. a xxxxx. xxxxxxxx | X05XX01 zanamivir, X05XX02 xxxxxxxxxxx |
62 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx | 62/1 | Imunoglobuliny xxxxxxxx xxxxxx, x.x. | J06BA01 xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx xxxxxxxxxxxxxxx xxxxxxxx |
62/2 | xxxxxxxxxxxxxx xxxxxxxx lidské, x.x. | J06BA01 imunoglobuliny xxxxxxxx xxxxxx pro xxxxxxxxxx xxxxxxxx | ||
62/3 | Xxxxxxxxxxxxxx xxxxxxxx lidské, xx. | X06XX02 imunoglobuliny normální xxxxxx pro intravenózní xxxxxxxx | ||
63 | Xxxxxx | 63/1 | xxxxxx, parent. | X01XX01 paklitaxel, X01XX02 xxxxxxxxx |
64 | Inhibitory xxxxxxxxxxxxx | 64/1 | xxxxxxxxxx xxxxxxxxxxxxx, x.x. | X01XX04 xxxxxxxxx, X01XX05 xxxxxxxxx |
65 | Superaktivní xxxxxxx xxxxxxxxxxxx-xxxxxxxxx xxxxxxx | 65/1 | xxxxxxxxxxxx analoga gonadotropin-releasing xxxxxxx, xxxxxx. | L02AE02 xxxxxxxxxxx, X02XX03 xxxxxxxxx, X02XX04 triptorelin |
66 | Xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxx | 66/1 | xxxxxxxxxxxxx, x.x. | X02XX01 tamoxifen, X02XX02 toremifen |
66/2 | xxxxxxxxxx xxxxxxxx, x.x. | X02XX03 xxxxxxxxxx, X02XX04 xxxxxxxx, X02XX06 exemestan | ||
67 | Xxxxxxxxxxxxx | 67/1 | xxxxxxxxxxxxx, x.x. | X02XX01 xxxxxxxx, X02XX03 bikalutamid |
69 | Xxxxxxxxxxx a xxxx xxxxxx | 69/1 | interferony xxxx xxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, - xxxxxxxxxxxx xxxxx, parent. | X03XX01 xxxxxxxxxx alfa xxxxxxx, X03XX04 xxxxxxxxxx xxxx-2x, X03XX05 xxxxxxxxxx xxxx-2x |
69/2 | xxxxxxxxxxx xxxx-2 - xxxxxxxxxx xxxxx, xxxxxx. | X03XX11 xxxxxxxxxxxxx xxxx-2x, X03XX10 xxxxxxxxxxxxx alfa-2b | ||
69/3 | xxxxxxxxxxx a xxxxxxx xxxxxx k xxxxxxx xxxxxxxxxxx xxxxxxxx, xxxxxx. | X03XX07 xxxxxxxxxx beta-1a, X03XX08 xxxxxxxxxx xxxx-1x, X03XX13 xxxxxxxxxx xxxxxx, | ||
70 | Xxxxxxxxxxxxxx | 70/1 | xxxxxxxxxxxxxx- xxxxxxxxxx, p.o. x parent. (xxxxx xxxxxxxxxxx a xxxxxxxxxxxx) | X04XX02 xxxxxxxxxx, X04XX06 xxxxxxxx xxxxxxxxxxxxx, X04XX10 xxxxxxxxx, X04XX18 xxxxxxxxxx |
70/2 | xxxxxxxxxxxxxx - biologická, xxxxxx k xxxxxxx xxxxxxxxxxxx, kožních xxxx xxxxxxxxx xxxxxxxxxx, xxxxxx. | X04XX01 xxxxxxxxxx, L04AB02 xxxxxxxxxx, X04XX04 adalimumab, X04XX21 xxxxxxxxxxx, X04XX24 xxxxxxxxx | ||
71 | Xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx | 71/1 | xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx - xxxxxxxxxxxx, x.x. | X01XX05 diklofenak, X01XX01 xxxxxxxxx, X01XX05 lornoxikam, X01XX06 xxxxxxxxx, X01XX01 xxxxxxxxx, X01XX02 naproxen, X01XX03 xxxxxxxxxx, M01AE11 xxxxxxxx tiaprofenová, X01XX12 xxxxxxxxx, X01XX17 dexketoprofen, X01XX02 xxxxxxxx xxxxxxxxxxx, X01XX01 xxxxxxxxx, X01XX17 xxxxxxxxx |
71/2 | xxxxxxxxxxx antiflogistika, xxxx. aplikace | X01XX01 xxxxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX06 xxxxxxxxx, M01AE01 xxxxxxxxx, X01XX03 xxxxxxxxxx | ||
71/3 | xxxxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. | X01XX05 xxxxxxxxxx, X01XX01 xxxxxxxxx, M01AC06 meloxikam, X01XX03 xxxxxxxxxx, X01XX04 xxxxxxxxx | ||
71/4 | xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx COX 2 xxxxxxxxxx (xxxxxx), x.x. | X01XX01 xxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX05 xxxxxxxxxx | ||
73 | Centrálně působící xxxxxxxxxxxxx | 73/1 | centrálně xxxxxxxx xxxxxxxxxxxxx, x.x. | X03XX01 xxxxxxxx, M03BX02 xxxxxxxxx, X03XX04 xxxxxxxxxx, X03XX05 xxxxxxxxxxxxxxx, M03BX07 xxxxxxxxxx, X05XX01 mefenoxalon |
73/2 | xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx, xxxxxx. | M03BX04 tolperison, X03XX05 xxxxxxxxxxxxxxx | ||
74 | Xxxxxx x terapii x xxxxxxxxx xxxxxxxxxxx | 74/1 | xxxxxx x xxxxxxx a xxxxxxxxx xxxxxxxxxxx, vitamin X, x.x. | X11XX01 xxxxxxxxxxxxxx, X11XX05 xxxxxxxxxxxxxxx |
74/2 | xxxxxx x terapii x xxxxxxxxx xxxxxxxxxxx, xxxxxxxxxx xxxxxxxx D, p.o. | X11XX03 xxxxxxxxxxxx, X11XX04 xxxxxxxxxx | ||
74/3 | xxxxxx x xxxxxxx x profylaxi xxxxxxxxxxx, xxxxxxxxxxxx, x. x. | X05XX04 xxxxxxxx xxxxxxxxxxx, X05XX061xxxxxxxx xxxxxxxxxxx, X05XX07 kyselina risedronová, | ||
74/4 | xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, xxxxxxx příštitných xxxxxxx x xxxxxxx, xxxxxx. | X05XX02 xxxxxxxxxxx, X05XX03 xxxxxxxxxxx | ||
75 | Xxxxxx x terapii hyperkalcémie x/xxxx xxxxxxxxx u xxxxxxxxx onemocnění | 75/1 | xxxxxx x terapii xxxxxxxxxxxxx x/xxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxxx, xxxxxx. | M05BA02 kyselina xxxxxxxxxx, M05BA03 kyselina xxxxxxxxxxx, X05XX06 xxxxxxxx xxxxxxxxxxx, X05XX08 xxxxxxxx xxxxxxxxxxx |
76 | Anestetika xxxxxxx | 76/1 | xxxxxxxxxx xxxxxxx, xxxxxx. | X01XX01 xxxxxxxx, N01AH02 xxxxxxxxxx, X01XX03 sufentanil, N01AH06 xxxxxxxxxxxx |
77 | Anestetika xxxxxxx | 77/1 | anestetika xxxxxxx, parent. | N01AB02 xxxxxxx, X01XX01 bupivakain, X01XX03 xxxxxxxxxx, N01BB09 xxxxxxxxxx, X01XX10 xxxxxxxxxxxxxx, X01XX xxxxxxxxxx |
78 | Xxxxxxx | 78/1 | silné xxxxxxx, x.x. | X02XX03 xxxxxxxxxxx, X02XX05 xxxxxxxx |
78/2 | xxxxx xxxxxxx, xxxxxxxxx. xxxxxxxx | X02XX03 xxxxxxxx, X02XX01 xxxxxxxxxxx | ||
78/3 | xxxxx xxxxxxx, p.o. | X02XX08 xxxxxxxxxxxxx, X02XX02 tramadol | ||
79 | Xxxxxxxxxx-xxxxxxxxxxxx | 79/1 | xxxxxxxxxx-xxxxxxxxxxxx, x.x. | X02XX01 xxxxxxxx acerylsalicylová, X02XX02 xxxxxxxxx, X02XX02 xxxxxxxxxx, X02XX01 xxxxxxxxxxxx |
79/2 | xxxxxxxxxx-xxxxxxxxxxxx, xxxxxx. | X02XX02 metamizol X02XX01 paracetarnol | ||
80 | Xxxxxxxxxxxxx x xxxxxxx xxxxxxxx xxxxxxxx | 80/1 | xxxxxxxxxxxxx x terapii xxxxxxxx xxxxxxxx, xxxxxxxxxx xxxxxxxx xxxxxxxxxx, x.x. | X02XX01 xxxxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx, X02XX06 xxxxxxxxxx, X02XX07 xxxxxxxxxxxx |
80/2 | xxxxxxxxxxxxx k xxxxxxx akutního xxxxxxxx, xxxxxxxxxx agonisté xxxxxxxxxx, xxxxx. aplikace | X02XX01 xxxxxxxxxxx, N02CC03 xxxxxxxxxxxx | ||
81 | Xxxxxxxxxxxxxx xxxx | 81/1 | antiepileptika xxxx, x.x. | X03XX12 gabapentin, X03XX16 pregabalin |
82 | Xxxxxxxxxxxxxxxx | 82/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxx, x.x. | X04XX02 xxxxxxxxx, X04XX04 xxxxxxxxxxx, X04XX01 xxxxxxxxxxx |
82/2 | xxxxxxxxxxxxxxxx, xxxxxxxx xxxxxxxxx, p.o. | X04XX04 ropinirol, N04BC05 xxxxxxxxxxx | ||
82/3 | xxxxxxxxxxxxxxxx, inhibitory XXXX, p.o. | X04XX01 xxxxxxxx, X04XX02 xxxxxxxxx | ||
82/4 | xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX, x. x. | X04XX01 xxxxxxxxx, N04BD02 rasagilin | ||
83 | Antipsychotika xxxxxxxxxxxx | 83/1 | xxxxxxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx - I. xxxxx, p. x. | X05XX01 chlorpromazin X05XX03 xxxxxxxxxxxxxx, N05AF05 zuklopentixol |
83/2 | xxxxxxxxxxxxxx, - xxxxxxxxxxxx xxxxxxxx II. xxxxx, x.x. | X05XX01 xxxxxxxxxxx, X05XX01 flupentixol | ||
83/3 | xxxxxxxxxxxxxx, xxxxxxxxxxxx, parent. - xxxxxxxxx | X05XX01 chlorpromazin, X05XX02 xxxxxxxxxxxxxx, N05AD01 xxxxxxxxxxx, N05AF05 zuklopentixol | ||
83/4 | xxxxxxxxxxxxxx, xxxxxxxxxxxx - X. xxxxx, xxxxxx. - xxxxxxx | N05AB02 xxxxxxxxxx, N05AF oxyprothepin | ||
83/5 | xxxxxxxxxxxxxx, xxxxxxxxxxxx - xX. xxxxx, xxxxxx. - depotní | X05XX01 xxxxxxxxxxx, X05XX01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/6 | antipsychotika x xxxxxx antipsychotickým xxxxxxxxxxx, x.x. | X05XX03 xxxxxxxx, X05XX03 xxxxxxx | ||
84 | Xxxxxxxxxxxxxx - XX. xxxxxxxx | 84/1 | xxxxxxxxxxxxxx xxxxx xxxxx xxx selhání xxxxxxxxxxx, x.x. | X05XX03 xxxxxxxxx, X05XX04 quetiapin, X05XX05 xxxxxxxxxx, N05AX11 xxxxxxx |
84/2 | xxxxxxxxxxxxxx xxxxx volby - xxxxxxxxx, x.x. | X05XX04 ziprasidon, X05XX03 xxxxxxxxx, N05AX12 xxxxxxxxxxx | ||
84/3 | xxxxxxxxxxxxxx speciální, xxxxxx. - xxxxxxxxx | N05AE04 xxxxxxxxxx, X05XX03 olanzapin | ||
85 | Anxiolytika | 85/1 | xxxxxxxxxxx, benzodiazepiny, p.o. | X05XX01 diazepam, X05XX02 xxxxxxxxxxxxxxx, N05BA03 medazepam, X05XX04 xxxxxxxx, X05XX08 xxxxxxxxxx, X05XX09 xxxxxxxx, X05XX12 xxxxxxxxxx, X05XX23 xxxxxxxxx |
86 | Xxxxxxxxxxxxx | 86/x | antidepresiva, xxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxx, p.o. | X06XX02 xxxxxxxxx, N06AA04 xxxxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX16 xxxxxxxxx, X06XX21 xxxxxxxxxx, X06XX03 xxxxxxxxx |
86/2 | antidepresiva, xxxxxxxxxx xxxxxxxxxx reuptake xxxxxxxxx xxxxxxxx xxxxxxx xxxxxxxxxxxxx xxxxxx (XXXX, XXXX, XXXX); xxxxxxxxxxxx inhibitory xxxxxxxxxxxxxxxx (XXXX); enhancery xxxxxxxx serotoninu (XXX), x. x. | X06XX03 xxxxxxxxx, N06AB04 xxxxxxxxxx, X06XX05 xxxxxxxxx, N06AB06 xxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 escitalopram, X06XX05 xxxxxxxx, N06AX14 xxxxxxxxx | ||
86/3 | xxxxxxxxxxxxx, xxxxxxxxxx inhibitory xxxxxxxx xxxxxxxxx xxxxxxxx xx dva xxxxxxxxxxxxx xxxxxxx (XXXX, XxXXX, XXXX), p.o. | X06XX11 xxxxxxxxxx, N06AX16 xxxxxxxxxx, X06XX17 xxxxxxxxxxx, N06AX xxxxxxxxx | ||
87 | Léčiva x xxxxxxx xxxxxxx Xxxxxxxxxxxx xxxx | 87/1 | xxxxxx x xxxxxxx Xxxxxxxxxxxx xxxxxxx, p.o. x transderm. xxxxxxxx | X06XX02 xxxxxxxxx, N06DA03 xxxxxxxxxxx, N06DA04 galantamin, X06XX01 xxxxxxxx |
88 | Xxxxxxxxxx | 88/1 | xxxxxxxxxx, x.x. | N06BX02 xxxxxxxxx, X06XX03 xxxxxxxxxx, N06BX18 xxxxxxxxxx, X06XX02 extrakty x Ginkgo biloba |
88/2 | xxxxxxxxxx, xxxxxx. | N06BX03 xxxxxxxxx, X06XX18 xxxxxxxxxx | ||
89 | Xxxxxxxxxxxxxxxxxxx | 89/1 | xxxxxxxxxxxxxxxxxxx, x.x. (xxxxx xxxxxxxxxx) | X07XX01 xxxxxxxxxx, X07XX02 pyridostigmin, X07XX30 xxxxxxxxxx |
90 | Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx a x xxxxxxxxx alergické xxxxxxxxx | 90/1 | xxxxxx xxxxxxxxx x lokální xxxxxxx x x xxxxxxxxx xxxxxxxxx xxxxxxxxx, kortikosteroidy, xxxxxxxxxx. xxxxxxxx | X01XX01 xxxxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX06 mometason, R01AD08 xxxxxxxxxx |
90/2 | xxxxxx používaná x xxxxxxx terapii x x xxxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxx. xxxxxxxx | X01XX02 xxxxxxxxxxxx, R01AC03 azelastin | ||
91 | Léčiva používaná x xxxxxxx xxxxxxx xxxxxxx | 91/1 | léčiva Xxxxxx používaná k xxxxxxx xxxxxxx astmatu, x.x. | X03XX02 xxxxxxxxxx, X03XX08 xxxxxxxxxx, X03XX13 xxxxxxxxxxx |
91/2 | léčiva Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, xxxxx. xxxxxxxx | X03XX02 xxxxxxxxxx, X03XX03 xxxxxxxxxx, X03XX04 xxxxxxxxx a jiná xxxxxxxxxxxxx | ||
92 | Xxxxxxxxxxx xxxxxxxxxxxxx - kortikosteroidy | 92/1 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxx, - ve xxxxx aerosolu, xxxxxxxx x xxxxxxx, inhal. xxxxxxxx | X03XX02 budesonid, X03XX05 flutikason, X03XX08 xxxxxxxxxx |
92/2 | xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxx - xxxxxx, xxxxx aplikace | R03BA02 xxxxxxxxx, R03BA05 xxxxxxxxxx | ||
93 | Preventivní antiastmatika | 93/1 | xxxxxxxxxxx xxxxxxxxxxxxx xx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx, xxxxx. xxxxxxxx | R03AC12 xxxxxxxxxx, X03XX13 formoterol |
93/2 | preventivní xxxxxxxxxxxxx, xxxxxxx, x.x. | X03XX04 xxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X03XX05 xxxxxxxxxx (xxxxxxxxxxx lékové xxxxx) | ||
93/3 | preventivní xxxxxxxxxxxxx, xxxxxxxxxxxxxxxx, x. o. | X03XX01 zafirlukast, R03DC03 xxxxxxxxxxx | ||
93/4 | preventivní xxxxxxxxxxxxx, xxxxxxxxxxxxxxxx a xxxxxxxxxxxx, xxxxx. xxxxxxxx | X03XX01 xxxxxx ipratropia, X03XX04 xxxxxx xxxxxxxxx | ||
93/5 | preventivní xxxxxxxxxxxxx, xxxxx kombinace, xxxxx. xxxxxxxx | X03XX12 xxxxxxxxxx/ X03XX05 flutikason, X03XX13 formoterol/ X03XX02 xxxxxxxxx, X03XX13 xxxxxxxxxx/ X03XX01 beclomethason | ||
94 | Xxxxxxxxxxxxx | 94/1 | expektorancia, x.x. | X05XX01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxx, R05CB06 xxxxxxxx, R05CB15 xxxxxxxxx |
94/2 | xxxxxxxxxxxxx, xxxxxx. x xxxxx. xxxxxxxx | R05CB01 xxxxxxxxxxxxx, X05XX02 bromhexin, X05XX03 xxxxxxxxxxxx, X05XX05 xxxxx, R05CB06 ambroxol | ||
95 | Xxxxxxxxxx | 95/1 | xxxxxxxxxx, p. x. (xxxxx xxxxxxx) | X05XX01 xxxxxxxxxxx, X05XX09 xxxxxxxxxxxxxxx, X05XX13 xxxxxxxxx, R05DB19 xxxxxxxxxxx, X05XX27 levodropropizin |
96 | Antihistaminika | 96/1 | xxxxxxxxxxxxxxx xxxxxxxxx, x.x. | X06XX04 klemastin, R06AB03 xxxxxxxxxx, X06XX02 promethazin, X06XX bisulepin, X06XX02 xxxxxxxxxxxxx, X06XX17 xxxxxxxxx |
96/2 | xxxxxxxxxxxxxxx xxxxxxxxxxx, x.x. | X06XX07 cetirizin, R06AE09 xxxxxxxxxxxxx, R06AX13 xxxxxxxxx, X06XX27 desloratadin | ||
97 | Xxxxxxxxxxxxx - xxxxxxxxxxxxx | 97/1 | oftalmologika, xxxxxxxxxxxxxxx, xxxxxxxxx, lok. | X01XX11 xxxxxxxxx, S01AX13 xxxxxxxxxxxxx, X01XX17 xxxxxxxxxxxx, X01XX19 xxxxxxxxxxxx |
97/2 | xxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx ostatní, xxx. | X01XX01 chloramfenikol, X01XX11 xxxxxxxxxx, S01AA12 xxxxxxxxxx, X01XX13 xxxxxxx xxxxxxxxx, X01XX24 xxxxxxxxx, X01XX04 xxxxxxxxxxxx | ||
97/3 | xxxxxxxxxxxxx, antiinfektiva, xxxxxxxxxxx, xxx. | X01XX03 xxxxxxxxx, X01XX09 xxxxxxxxxxx | ||
98 | Xxxxxxxxxxxxx - xxxxxxxxxxxxxxx | 98/1 | oftalmologika, xxxxxxxxxxxxxxx xxxx řady, xxx. | X01XX01 dexamethason, X01XX02 hydrokortison |
98/2 | xxxxxxxxxxxxx, xxxxxxxxxxxxxxx druhé řady, xxx. | S01BA03 xxxxxxxx, X01XX04 xxxxxxxxxxx, X01XX07 xxxxxxxxxxxxxx | ||
99 | Xxxxxxxxxxxxx - xxxxxxxxxxxxxx xxxxxx | 99/1 | oftalmologika, xxxxxxxxxxxxxx xxxxxx, xxx. | X01XX01 xxxxxxxxxxx, X01XX03 xxxxxxxxxx |
100 | Xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx | 100/1 | xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx xxxx parasympatomimetika, xxx. | S01EA04 xxxxxxxx, X01XX05 xxxxxxxxxx, S01EB01 xxxxxxxxxx |
100/2 | xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx, xxxxxxxxxx karboanhydrázy, xxx. | X01XX03 xxxxxxxxxx, X01XX04 xxxxxxxxxxx | ||
100/3 | xxxxxxxxxxxxx používaná x xxxxxxx xxxxxxxx, xxxxxxxxxxxxx, xxx. | X01XX01 xxxxxxx, X01XX02 xxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX05 xxxxxxxxx | ||
100/4 | xxxxxxxxxxxxx xxxxxxxxx x terapii glaukomu, xxxxxxxxxxxxxx nebo xxxxxx xxxxxxxx, xxx. | S01EE01 xxxxxxxxxxx, X01XX02 imoproston, X01XX03 xxxxxxxxxxx, X01XX04 xxxxxxxxxx | ||
101 | Oftalmologika - xxxxxxxxxx x xxxxxxxxxxxx | 101/1 | xxxxxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxxxx, xxx. | X01XX01 xxxxxxx, X01XX04 xxxxxxxxxxxxx, X01XX06 xxxxxxxxxx, S01FB01 fenylefrin (xxxxxxxxxxx 10 % xxxx xxxx) |
102 | Xxxxxxxxxxxxx - xxxxxxxxxxxx (xxxxx kortikosteroidů) | 102/1 | xxxxxxxxxxxxx, xxxxxxxxxxxx - xxxxxxxxxxxxxxx, xxx. | X01XX52 xxxxxxxxxx kornbinace, S01GX02 xxxxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX07 xxxxxxxxx, X01XX10 xxxxxxxxx |
102/2 | oftalmologika, xxxxxxxxxxxx - xxxxxxxxxxxxx xxxxxxx xxxxx, xxx. | X01XX01 xxxxxxxx kromoglyková, S01GX03 xxxxxxxx xxxxxxxxxx, S01GX05 xxxxxxxxx, S01GX08 xxxxxxxxx, X01XX09 xxxxxxxxxx | ||
103 | Xxxxxx používaná x xxxxxxx xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx | 103/1 | xxxxxx k xxxxxxx xxxxx podmíněné makulární xxxxxxxxxx, lok. | S01LA01 xxxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX04 ranibizumab |
104 | Xxxxxxxxxxxx xxxxxxxx alergenů | 104/1 | terapeutické extrakty xxxxxxxx - nestandardizované, xxxxxxxxxxx, perorální | V01AA xxxxxxxx xxxxxxxx |
104/2 | xxxxxxxxxxxx xxxxxxxx alergenů - xxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/3 | xxxxxxxxxxxx extrakty xxxxxxxx - xxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxx | V01AA extrakty xxxxxxxx | ||
104/4 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - nestandardizované, xxxxxxxx xxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/5 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxx depotní | X01XX xxxxxxxx xxxxxxxx | ||
104/6 | xxxxxxxxxxxx extrakty xxxxxxxx - xxxxxxxxxxxxxxx xxxxxxxx xxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/7 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - standardizované, xxxxxxxx xxxxxxx | X01XX xxxxxxxx alergenů | ||
105 | Xxxxx xxx xxxxxxxxx xxxxxxx | 105/1 | testy xxx xxxxxxxxx xxxxxxx - xxxxxxxxxxxxx | V04CL xxxxx pro xxxxxxxxx xxxxxxx |
105/2 | xxxxx xxx xxxxxxxxx xxxxxxx - xxxxx xxxxx | X04XX xxxxx xxx xxxxxxxxx xxxxxxx | ||
106 | Léčiva xxxxxxxxx x terapii xxxxxxxxxxxx a xxxxxxxxxxxxxxx | 106/1 | xxxxxx x xxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxxxxx, x.x. | X03XX02 xxxxxxxxx, V03AE03 xxxxxxxxxxxxxxx |
107 | Xxxxxx pro xxxxxxx xxxxxxx xxxxxxxxxxx | 107/1 | definované směsi xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | X06XX01 |
107/2 | xxxxxxxxxx směsi aminokyselin xxx xxxxxxxxxxxx x xxxxxxx sacharidů a xxxx pro xxxx xx 1 roku (xxxxxxxx formy na xxxxx aminokyselin) | X06XX02 | ||
107/3 | xxxxxxxxxx xxxxx aminokyselin xxx xxxxxxxxxxxx xxx xxxxxxx (xxxxxxxx xxxxx xx obsah aminokyselin) | X06XX04 | ||
107/4 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx fenylalaninu (xxxxxxxxx fonny xx xxxxx aminokyselin) | X06XX05 | ||
107/5 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxxxx (dávkované xxxxx xxxxxx xx xxxxx xxxxxxxxxxxx) | X06XX11 | ||
107/6 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxx pro xxxx xx 1 xxxx x xxxxxxxx metabolismu xxxxx xxxxxxxx (práškové xxxxx na obsah xxxxxxxxxxxx) | X06XX12 | ||
107/7 | xxxxxxxxxx xxxxx xxxxxxxxxxxx aminokyselin xxx xxxxxxxx xxx 1 rok s xxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX13 | ||
107/8 | definované směsi xxxxxxxxxxxx xxx isoleucinu, xxxxxxx x xxxxxx xx xxxxxxxxx x xxxx xxx xxxx xx 1 roku - kompletní xxxxxxxxx xxxxxx (xxxxxxxx xxxxx xx obsah aminokyselin) | X06XX14 | ||
107/9 | definované xxxxx xxxxxxxxxxxx xxx isoleucinu, xxxxxxx x xxxxxx xxx xxxx do 1 xxxx (práškové xxxxx xx xxxxx xxxxxxxxxxxx) | V06DD14 | ||
107/10 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, leucinu a xxxxxx xxx xxxxxxxx xxx 1 rok (xxxxxxxx formy xx xxxxx aminokyselin) | X06XX15 | ||
107/11 | xxxxxxxxxx xxxxx aminokyselin xxx xxxxxxxxxx, methioninu, xxxxxxxxx x xxxxxx xxx xxxx x xxxxxxxxxxxxxx a xxxxxxxxxxx xxxxxxxx do 1 xxxx (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) | X06XX16 | ||
107/12 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx x xxxxxx xxx pacienty x metylmalonovou a xxxxxxxxxxx acidémií nad 1 xxx (xxxxxxxx xxxxx na obsah xxxxxxxxxxxx) | X06XX17 | ||
107/13 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxx xxx xxxx xx 1 xxxx (xxxxxxxx xxxxx na xxxxx xxxxxxxxxxxx) | X06XX18 | ||
107/14 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxx xxx xxxxxxxx nad 1 xxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX19 | ||
107/15 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx lysinu x se xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx xxxx s glutarovou xxxxxxxx do 1 xxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | X06XX20 | ||
107/16 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxx x xx xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxx xxxxxxxx nad 1 xxx (práškové xxxxx xx xxxxx aminokyselin) | X06XX21 | ||
107/17 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx methioninu xxxxxxxxx L-cystinem xxx xxxx x homocystinurií xx 1 xxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | X06XX22 | ||
107/18 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx obohacené X-xxxxxxxx pro pacienty x xxxxxxxxxxxxxx xxx 1 xxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX23 | ||
107/19 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxx xx xxxxxxxxx x xxxx xxx děti xx 1 xxxx - kompletní xxxxxxxxx xxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX26 | ||
107/20 | definované xxxxx xxxxxxxxxxxx bez xxxxxxxx x xxxxxxxxxxxx xxx xxxx xx 1 xxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX26 | ||
107/21 | definované směsi xxxxxxxxxxxx bez tyrosinu x xxxxxxxxxxxx xxx xxxxxxxx xxx 1 xxx (práškové xxxxx xx xxxxx aminokyselin) | X06XX27 | ||
107/22 | xxxxxxxxxx xxxxx xxxxxxxxxxxx včetně xxxxxxxxx x xxxxxxx x xxxxxx obsahem xxxxxxxxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | V06DD29 | ||
108 | Xxxxxx enterální xxxxxx | 108/1 | Xxxxxxxxx xxxxxx standardní - x xxxxxx xxxxx | X06XX01 |
108/2 | Xxxxxxxxx xxxxxx xxxxxxxxxx - hyperkalorická | X06XX01 | ||
108/3 | Xxxxxxxxx výživa xxxxxxxxxx - x xxxxxxxx xxxxxxxx isokalorická | X06XX02, X06XX04 | ||
108/4 | Xxxxxxxxx xxxxxx xxxxxxxxxx - x doplňkem vlákniny xxxxxxxxxxxxxxx | V06EB02, X06XX04 | ||
108/5 | Xxxxxxxxx výživa speciální - hyperkalorická xxx xxxx | V06EB03 | ||
108/6 | Xxxxxxxxx xxxxxx xxxxxxxxx - xxxxxxxxxxxxxx x xxxxxxxx xxxxxxxx anebo xxxxxxxx x xxxxxxxx | X06XX05, X06XX06 | ||
108/7 | Xxxxxxxxx xxxxxx xxxxxxxxx - xxxxxx xxx xxxxx xxxxxxxxx xxxxxxx | V06EB10 | ||
108/8 | Xxxxxxxxx xxxxxx xxxxxxxxx - x xxxxxxxx xxxxxxxx, xxxxxxxx x xxxxx | X06XX11 | ||
108/9 | Xxxxxxxxx xxxxxx xxxxxxxxx - x xxxxxxxx xxxxxxxxxxxxxx a xxxxxxxxxxxx | X06XX07, X06XX12, X06XX13, X06XX14, V06EB15, X0XXX16 | ||
108/10 | Polymerní xxxxxx xxxxxxxxx - diabetická | X06XX08 | ||
108/11 | Xxxxxxxxx xxxxxx xxxxxxxxx - s xxxxxxxx MCT olejů | X06XX09 | ||
108/12 | Xxxxxxxxxxxxxxx výživa xxxxxx | X06XX01 | ||
108/13 | Zahušťovadla | X06XX01 | ||
109 | Výživy - xxxxxxx mléka | 109/1 | náhrady xxxxx x xxxxxxx bílkoviny xxxxxxxxx xxxxx | X06XX01 |
109/2 | xxxxxxx mléka x xxxxxxx xxxxxxxxxxx hydrolyzátem | X06XX02 | ||
109/3 | xxxxxxx xxxxx x xxxxxx xxxxxxx xxxxxxx x xxxxxxx xxxxxxxxxxx hydrolyzátem | X06XX04 | ||
109/4 | xxxxxxxxx kojenecká xxxxxx x obsahem xxxxxxxxxxxx xxxxxxxxxxxx | X06XX | ||
110 | XXX xxxxxxxxxxxxx nízkoosmolární xxxxxxxxxxx xxx xxxxxxxxxx xxxxx neionické | 110/1 | XXX xxxxxxxxxxxxx nízkoosmolární xxxxxxxxxxx xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx jodu 150 xx/xx, parent. | X08XX09 xxxxxxxxx, V08AB10 xxxxxxxx |
110/2 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - neionické - xxxxxxxxxxx xxxx 200 xx/xx, parent. | V08AB04 xxxxxxxxxx, V08AB10 xxxxxxxx | ||
110/3 | XXX xxxxxxxxxxxxx nízkoosmolární xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 240 xx/xx, xxxxxx. | V08AB02 xxxxxxx, V08AB05 xxxxxxxx, X08XX07 xxxxxxxx | ||
110/4 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 300 xx/xx, xxxxxx. | V08AB02 xxxxxxx, X08XX04 xxxxxxxxxx, X08XX05 xxxxxxxx, V08AB07 xxxxxxxx, X08XX10 iomeprol, V08AB11 xxxxxxxxxx | ||
110/5 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx xxxxx - neionické - xxxxxxxxxxx jodu 320 xx/xx, parent. | X08XX03 xxxxxxxx ioxagliková, X08XX07 xxxxxxxx, X08XX09 xxxxxxxxx | ||
110/6 | RTG vodorozpustné xxxxxxxxxxxxxx xxxxxxxxxxx rtg-kontrastní xxxxx - xxxxxxxxx - xxxxxxxxxxx jodu 350 xx/xx, xxxxxx. | X08XX02 xxxxxxx, X08XX07 xxxxxxxx, X08XX10 xxxxxxxx, X08XX11 xxxxxxxxxx | ||
110/7 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 370 mg/ml, xxxxxx. | X08XX04 Xxxxxxxxx, X08XX05 xxxxxxxx | ||
111 | Xxxxxxxxxx xxxxx pro xxxxxxxxx ultrazvukem | 111/1 | xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxx, xxxxxx. | X08XX01 xxxxxxxxxxxx x xxxxxxxxx, X08XX05 sulfur xxxxxxxxxxx |
*) Xxxx-xx xxxxxxx x xxxxxxxxx xxxxxxxxxx xxxxxxx xxxxx podání, xxx xx takové xxxxxxxxxx xxxxxxx xxxxxx xxxxxxx x xxxxxx xxxxxxxxxxxx zaměnitelné xxxxxx xxxxxxxxx x xxxxxxxx xxxx blízkou xxxxxxxxx x xxxxxxxxxxx a xxxxxxxx klinickým xxxxxxxx, xxx xxxxxxx jejich xxxxx xxxxxx.
Čl. XX
Xxxx xxxxxxxx xxxxxx xxxxxxxxx patnáctým xxxx xxx xxx jejího xxxxxxxxx.
Xxxxxxxxxx:
Xxxxxxxxx v. x.
Xxxxxxxxx
Xxxxxx předpis č. 114/2009 Xx. nabyl xxxxxxxxx xxxx 13.5.2009.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.